PR Newswire Launches Amplify: AI Platform to Accelerate Modern PR and Communications Capabilities
A new platform gives communicators the tools to transform a single press…
From Confusion to Clarity: How Fincover Is Cracking the Health Insurance Code for Indian Families in 2025
CHENNAI, India, Sept. 9, 2025 /PRNewswire/ -- In India, a single hospital…
IAN Group appoints Chintan Thakkar as Group CEO and Senior Managing Partner, IAN Alpha Fund
NEW DELHI, Aug. 19, 2025 /PRNewswire/ -- IAN Group, India's single largest…
Nexteer Unveils Its MotionIQ Software Suite for Intelligent Motion Control
Accelerates Development; Enhances Quality, Safety, Performance & Cost EfficiencyLeverages Nexteer's Chassis Domain…
Kavalan Makes History at Tokyo Whisky and Spirits Competition 2025 Clinching Double ‘Best of the Best Single Malt’
TWSC Says Their Top 'Best of the Best' Award Has Never Been Awarded…
Knot.dating Sets 50L+ Income Criteria for Men, None for Women
A new elite matchmaking app, Knot.dating has put a policy of allowing…
Entrepreneur Nirvaan Birla Releases His Musical Debut with Soulful Track Shankaraa, a Tribute to Lord Shiva on Shravan
MUMBAI, India, July 24, 2025 /PRNewswire/ -- After much anticipation, Shankaraa, the…
The Future Now: adidas Reveals the CLIMACOOL LACED
Following on from the release of the CLIMACOOL shoe in 2024, the…
Capcoms Devil May Cry 5 Sales Top 10 Million Units!
– Capcom further enhances global brand awareness with its Single Content Multiple…
ImPact Biotech Announces Treatment of First Patient in Phase 1 Clinical Trial of Padeliporfin VTP in Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma (PDAC)
June 05, 2025 16:31 ET | Source: ImPact Biotech – Previously inoperable…
